Summary:
Original Link:
Original Article:
Prior notification of a concentration (Case M.12067 – ALBA / BPCE / CDC / NEMO FRANCE)
Candidate case for simplified procedure
(Text with EEA relevance)
(C/2025/4516)
1.
On 30 July 2025, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004.
This notification concerns the following undertakings:
— Alba NGM Co-Invest S.L.P.S (“ANCI”, France), controlled by Alba Infra Founding Partners SAS (“Alba”, France),
— Mirova Energy Transition 6 S.L.P. (“MET 6”, France), controlled by BPCE SA (“BPCE”, France),
— Caisse des Dépôts et Consignations (“CDC”, France), controlled by the French State,
— NEMO France (France).
ANCI, MET 6 and CDC will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of NEMO France.
The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.
2.
The business activities of the undertakings concerned are the following:
— ANCI is a professional fund managed by Alba, an independent fund manager that invests, inter alia, in renewable energy projects in Europe,
— MET 6 is an investment fund managed by Mirova SA, a management company controlled by BPCE. BPCE operates in the retail banking and insurance sectors in France. It also provides asset and wealth management services and wholesale banking services worldwide,
— CDC is a French public-sector institution with specific legal status that pursues public-interest tasks and, through its subsidiaries, carries on business open to competition, principally in France.
3.
The business activities of the undertaking NEMO France will be the following: a platform for investing in projects related to low-carbon mobility and distributed renewable energy systems primarily in France.
4.
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
Pursuant to the Commission Notice on a simplified treatment for certain concentrations under Council Regulation (EC) No 139/2004 on the control of concentrations between undertakings it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.
5.
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.12067 – ALBA / BPCE / CDC / NEMO FRANCE
Observations can be sent to the Commission by email or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Postal address:
European Commission
Directorate-General for Competition
Merger Registry
1049 Bruxelles/Brussel
BELGIQUE/BELGIË